These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 6182761)
21. Genetic detoxification of an aroA Salmonella enterica serovar Typhimurium vaccine strain does not compromise protection against virulent Salmonella and enhances the immune responses towards a protective malarial antigen. McKelvie ND; Khan SA; Karavolos MH; Bulmer DM; Lee JJ; DeMarco R; Maskell DJ; Zavala F; Hormaeche CE; Khan CM FEMS Immunol Med Microbiol; 2008 Mar; 52(2):237-46. PubMed ID: 18177343 [TBL] [Abstract][Full Text] [Related]
22. Immunization of mice with live oral vaccine based on a Salmonella enterica (sv Typhimurium) aroA strain expressing the Escherichia coli O111 O antigen. Wang L; Curd H; Reeves PR Microb Pathog; 1999 Jul; 27(1):55-9. PubMed ID: 10371709 [TBL] [Abstract][Full Text] [Related]
23. [Oral immunization with non-living microorganisms or their antigens. 14. Possibilities of active and passive immunization of baby mice against a S. typhi murium infection]. Raettig H; Ganze B Zentralbl Bakteriol Orig A; 1971 Nov; 218(3):310-9. PubMed ID: 4400267 [No Abstract] [Full Text] [Related]
24. Experimental study of the mixed (oral-intradermal) vaccination method in enteric diseases. Dimache G; Croitoru M; Dimache A Roum Arch Microbiol Immunol; 1996; 55(3):215-23. PubMed ID: 9256023 [TBL] [Abstract][Full Text] [Related]
25. Comparison of the abilities of Salmonella typhimurium rpoS, aroA and rpoS aroA strains to elicit humoral immune responses in BALB/c mice and to cause lethal infection in athymic BALB/c mice. Coynault C; Norel F Microb Pathog; 1999 Jun; 26(6):299-305. PubMed ID: 10343058 [TBL] [Abstract][Full Text] [Related]
26. Immune response induced by Salmonella typhimurium defective in ppGpp synthesis. Na HS; Kim HJ; Lee HC; Hong Y; Rhee JH; Choy HE Vaccine; 2006 Mar; 24(12):2027-34. PubMed ID: 16356600 [TBL] [Abstract][Full Text] [Related]
27. Cross-protection against Salmonella enteritidis infection in mice. III. Delayed hypersensitivity reaction and clearance of the challenge organism. Padmanaban VD; Mittal KR Acta Microbiol Acad Sci Hung; 1979; 26(4):293-300. PubMed ID: 397733 [TBL] [Abstract][Full Text] [Related]
28. Salmonella type III-mediated heterologous antigen delivery: a versatile oral vaccination strategy to induce cellular immunity against infectious agents and tumors. Panthel K; Meinel KM; Sevil Domènech VE; Trülzsch K; Rüssmann H Int J Med Microbiol; 2008 Jan; 298(1-2):99-103. PubMed ID: 17719275 [TBL] [Abstract][Full Text] [Related]
29. [An ELISA study of the intestinal and serum anti-LPS antibody response in BALB/c mice fed with various mutants of "Salmonella typhi-murium" (author's transl)]. Lafont S; Dumont JM; Ivanoff B; Fontanges R Ann Microbiol (Paris); 1981; 132A(1):59-68. PubMed ID: 7020524 [TBL] [Abstract][Full Text] [Related]
30. [Oral immunization with non-viable micro-organisms or their antigens. 15. Immunogenicity from fractions of S. typhi murium bacteria in the mouse protection test]. Birnschein E; Herrmann R; Kolb HJ; Brehmer W; Raettig H Zentralbl Bakteriol Orig A; 1972 Dec; 222(3):314-25. PubMed ID: 4145495 [No Abstract] [Full Text] [Related]
31. The use of strain LT2-Ml in identifying the protective antigens in a Salmonella typhimurium-derived ribosomal vaccine. Lin JH; Berry LJ J Reticuloendothel Soc; 1978 Feb; 23(2):135-43. PubMed ID: 342689 [No Abstract] [Full Text] [Related]
32. Dual role for macrophages in vivo in pathogenesis and control of murine Salmonella enterica var. Typhimurium infections. Wijburg OL; Simmons CP; van Rooijen N; Strugnell RA Eur J Immunol; 2000 Mar; 30(3):944-53. PubMed ID: 10741413 [TBL] [Abstract][Full Text] [Related]
33. Salmonellae activate complement differentially via the alternative pathway depending on the structure of their lipopolysaccharide O-antigen. Liang-Takasaki CJ; Grossman N; Leive L J Immunol; 1983 Apr; 130(4):1867-70. PubMed ID: 6187823 [TBL] [Abstract][Full Text] [Related]
34. Artificial Salmonella vaccines: O-antigenic oligosaccharide-protein conjugates induce protection against infection with Salmonella typhimurium. Svenson SB; Nurminen M; Lindberg AA Infect Immun; 1979 Sep; 25(3):863-72. PubMed ID: 387597 [TBL] [Abstract][Full Text] [Related]
35. Experimental salmonellosis: differential passive transfer of immunity with serum and cells obtained from ribosomal and ribonucleic acid-immunized mice. Venneman MR; Berry LJ J Reticuloendothel Soc; 1971 May; 9(5):491-502. PubMed ID: 4933607 [No Abstract] [Full Text] [Related]
37. [Oral immunisation with inactivated microorganisms or their antigens. 10. Serological primary and secondary response after oral vaccination with S. typhi murium-complete antigen in comparative animal experiments]. Raettig H; Buse A Zentralbl Bakteriol Orig; 1970; 214(2):216-30. PubMed ID: 4921227 [No Abstract] [Full Text] [Related]
38. [Phagocytic capacity of peritoneal exudate cells from rats immunized with a ribosomal preparation of Ty2 Salmonella typhi]. Cabrera-Contreras R; Escobar-Gutiérrez A; Gómez de León-Cruces P; Villanueva G Bol Med Hosp Infant Mex; 1990 Jan; 47(1):14-9. PubMed ID: 2337459 [TBL] [Abstract][Full Text] [Related]